Ignite Creation Date:
2025-12-25 @ 2:25 AM
Ignite Modification Date:
2025-12-26 @ 12:58 AM
Study NCT ID:
NCT03892434
Status:
UNKNOWN
Last Update Posted:
2019-03-27
First Post:
2019-03-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Bevacizumab Versus DEX Implant Followed by Bevacizumab in ME Secondary to BRVO
Sponsor:
Yeungnam University College of Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-18
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-18
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-06-18
Completion Date Type:
ESTIMATED
First Submit Date:
2019-03-26
First Submit QC Date:
None
Study First Post Date:
2019-03-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-26
Last Update Post Date:
2019-03-27
Last Update Post Date Type:
ACTUAL